500789-04-8 Usage
Uses
Used in Pharmaceutical Industry:
(R)-3-(M-FLUOROPHENYL)-BETA-ALANINE is used as a building block for the synthesis of pharmaceutical compounds due to its unique structural properties. The m-fluorophenyl group can potentially enhance the bioactivity and selectivity of the resulting drug molecules, making it a valuable component in the development of new therapeutic agents.
Used in Chemical Research:
(R)-3-(M-FLUOROPHENYL)-BETA-ALANINE is used as a chiral reference standard in chemical research for studying the effects of stereochemistry on compound properties and reactivity. Its unique spatial arrangement of atoms allows researchers to investigate the influence of chirality on various chemical processes and reactions.
Used in Biological Research:
(R)-3-(M-FLUOROPHENYL)-BETA-ALANINE is used as a probe in biological research to study the interactions between amino acids and other biomolecules. The m-fluorophenyl group can potentially modulate the binding affinity and specificity of the compound towards target proteins or enzymes, providing insights into the molecular mechanisms underlying various biological processes.
Used in Drug Delivery Systems:
(R)-3-(M-FLUOROPHENYL)-BETA-ALANINE can be used as a component in the design of drug delivery systems, where its unique properties may enhance the stability, solubility, or targeting of therapeutic agents. The m-fluorophenyl group may also contribute to the development of stimuli-responsive drug carriers, enabling the controlled release of drugs in response to specific biological or environmental triggers.
Check Digit Verification of cas no
The CAS Registry Mumber 500789-04-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,7,8 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 500789-04:
(8*5)+(7*0)+(6*0)+(5*7)+(4*8)+(3*9)+(2*0)+(1*4)=138
138 % 10 = 8
So 500789-04-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H18FNO4/c1-14(2,3)20-13(19)16-11(8-12(17)18)9-5-4-6-10(15)7-9/h4-7,11H,8H2,1-3H3,(H,16,19)(H,17,18)/t11-/m1/s1
500789-04-8Relevant articles and documents
BICYCLIC-PYRIMIDINEDIONE COMPOUNDS
-
Paragraph 0242; 0243, (2016/07/27)
The present invention provides novel bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease.
N-4-PIPERIDINYL COMPOUNDS AS CCR5 MODULATORS
-
Page 31, (2010/02/05)
The invention provides a compound of formula (I):[Chemical formula should be inserted here. Please see paper copy.] wherein R1, R2, R3, R3a, R4, R4a, R5, and R6 are as defined; or a pharmaceutically acceptable salt thereof or a solvate thereof; compositions containing these compounds, processes for preparing them and their use as modulators of chemokine activity (especially CCR5 activity).